# LITMUS Imaging Study

> **NCT05479721** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Oxford** · enrollment: 450 (estimated)

## Conditions studied

- NAFLD
- NASH
- NASH - Nonalcoholic Steatohepatitis
- Fibrosis, Liver
- Steatosis of Liver

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05479721
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-09-04
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2025-04-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05479721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05479721, "LITMUS Imaging Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05479721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*